STÄMM

Biomanufacturing everywhere

Switzerland · Founded 2013 · $17.0M raised

Founded
2013
Business Model
B2B
Website
stamm.bio
Total Funding
$17.0M
Last Round
$17.0M Series AFeb 2022
Rounds
1

About

Stämm is an advanced biomanufacturing company developing high-throughput bioprocessing solutions for biologics and cell therapy production. The company combines bioengineering, Bio AI, and continuous bioreactor technology to accelerate cell line development for clinical and commercial manufacturing. Its proprietary continuous bioreactor has been shown to increase antibody productivity by up to 30x in European and American pilots. Stämm also builds AI-powered computational platforms that model cell biomolecular behavior to accelerate wetlab bio-innovation cycles.

Summary

STÄMM is a Biotech company based in Switzerland, founded in 2013. It has raised $17.0M in total across 1 round, most recently a $17.0M Series A round in Feb 2022. Investors include Varana Capital, Draper Associates and Vista Equity Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2022
$17.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

STÄMM on Indexed.vc
<a href="https://indexed.vc/companies/stmm"><img src="https://indexed.vc/api/badge/company/stmm" alt="STÄMM on Indexed.vc" width="260" height="76" /></a>